ClinicalTrials.gg
Sign In

Drug

Bulumtatug fuvedotin clinical trials

studies test it
13
open now
13
in phase 3
4
first study started
2022

Keep track of what changes. Save the bulumtatug fuvedotin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

9MW2821
12
bulumtatug fuvedotin
1

Studies by the year they started

13 studies that test it; most in 2024 (4)

Studies that test bulumtatug fuvedotin, by start year
YearStudies
20223
20232
20244
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
6
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it.

Triple Negative Breast Neoplasms
4
Neoplasms
2
Uterine Cervical Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1

Who runs them

Industry 9 · Other 4

Mabwell (Shanghai) Bioscience Co., Ltd. (9) · Fudan University (2) · Peking University Third Hospital (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Often tested with

Tested in the same studies.

Toripalimab (4) · Trastuzumab rezetecan (2) · Tizetatug rezetecan (2) · Famitinib (2) · Trastuzumab (2) · Ruzaltatug rezetecan (1) · Notiretatug rezetecan (1) · Disitamab vedotin (1)

Studies

Open first, then newest update. How each study uses bulumtatug fuvedotin is read from its arms, and is right about nine times in ten.

Testing it · 13

Given in every arm · 3 — bulumtatug fuvedotin is usual care beside what is tested

Codes

What other systems call bulumtatug fuvedotin · ClinicalTrials.gg INT014693

  • UNII (FDA) 3L9KU8WUU3BULUMTATUG FUVEDOTINOne source FDA
  • NCI Thesaurus C200283Bulumtatug FuvedotinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.